Works about ORAL medication
Results: 3035
Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery.
- Published in:
- Jornal Vascular Brasileiro, 2024, v. 23, p. 1, doi. 10.1590/1677-5449.202301072
- By:
- Publication type:
- Article
Thromboprophylaxis in lower limb amputation surgery.
- Published in:
- Jornal Vascular Brasileiro, 2024, v. 23, p. 1, doi. 10.1590/1677-5449.202301442
- By:
- Publication type:
- Article
Clinical guidelines for a dry land: challenges in developing recommendations for DOAC management in emergent cardiac surgery.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2025, v. 67, n. 2, p. 1, doi. 10.1093/ejcts/ezaf015
- By:
- Publication type:
- Article
Validation of a whole blood coagulometer sensitive to the direct oral anticoagulants.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-92201-7
- By:
- Publication type:
- Article
Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody-related stroke.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-91739-w
- By:
- Publication type:
- Article
Ultrasonic instruments and concurrent antithrombotic medication in mastectomy: safe and effective.
- Published in:
- World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03712-6
- By:
- Publication type:
- Article
Comparative effect of oral drugs in improving spasticity of different etiology: a network meta-analysis.
- Published in:
- Postgraduate Medical Journal, 2025, v. 101, n. 1193, p. 212, doi. 10.1093/postmj/qgae126
- By:
- Publication type:
- Article
Oral Administration of Neratinib Maleate-Loaded Lipid–Polymer Hybrid Nanoparticles: Optimization, Physical Characterization, and In Vivo Evaluation.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 221, doi. 10.3390/pharmaceutics17020221
- By:
- Publication type:
- Article
Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 148, doi. 10.3390/pharmaceutics17020148
- By:
- Publication type:
- Article
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients—Results of the Prospective RADOA Registry.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 170, doi. 10.3390/ph18020170
- By:
- Publication type:
- Article
Development and Characterization of Biocompatible Faropenem-Coated Absorbable Monofilament Suture.
- Published in:
- Journal of International Oral Health, 2025, v. 17, n. 1, p. 50, doi. 10.4103/jioh.jioh_240_23
- By:
- Publication type:
- Article
Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 490, doi. 10.3390/biomedicines13020490
- By:
- Publication type:
- Article
Effect of Oral + Topical and Only Topical Tranaxamic Acid Application on Blood Loss and Postoperative Transfusion in Primary Total Hip Arthroplasty.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1275, doi. 10.3390/jcm14041275
- By:
- Publication type:
- Article
Gender Disparity in Oral Anticoagulation Therapy in Hospitalised Patients with Atrial Fibrillation During the Ongoing Syrian Conflict: Unbalanced Treatment in Turbulent Times.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1173, doi. 10.3390/jcm14041173
- By:
- Publication type:
- Article
Effects of Adopting Preventive Drug Lists on Medication Costs and Disparities by Income Over 2 Years: A Natural Experiment for Translation in Diabetes (NEXT-D) Study.
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 341, doi. 10.2337/dc24-0361
- By:
- Publication type:
- Article
Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review.
- Published in:
- Pharmacy, 2025, v. 13, n. 1, p. 18, doi. 10.3390/pharmacy13010018
- By:
- Publication type:
- Article
Medical Exploration: A Comprehensive Case Study of an Adrenal Mass Linked with Hepatitis C, Nephrectomy, and Multifaceted Patient Care.
- Published in:
- Annals of King Edward Medical University, 2024, v. 30, n. 4, p. 375, doi. 10.21649/akemu.v30i4.5601
- By:
- Publication type:
- Article
The Reconstructed Individual Patient Data from Kaplan–Meier (IPDfromKM) Method for Non-Inferiority Analyses: A New Potential Application.
- Published in:
- Methods & Protocols, 2025, v. 8, n. 1, p. 13, doi. 10.3390/mps8010013
- By:
- Publication type:
- Article
Analgesies in Pregnancy and Lactation: Safe Medication Practices.
- Published in:
- Compendium of Continuing Education in Dentistry (15488578), 2023, v. 44, n. 5, p. 242
- By:
- Publication type:
- Article
Analgesics in Pregnancy and Lactation: Safe Medication Practices.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Nitric Oxide‐Releasing Macromolecular Systems in Anticoagulant Therapeutics.
- Published in:
- Macromolecular Chemistry & Physics, 2023, v. 224, n. 23, p. 1, doi. 10.1002/macp.202300196
- By:
- Publication type:
- Article
Solid‐Acid Catalyzed Continuous‐Flow Aminolysis of Epoxides.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 70, p. 1, doi. 10.1002/chem.202403094
- By:
- Publication type:
- Article
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 133, doi. 10.1007/s10557-023-07521-5
- By:
- Publication type:
- Article
Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 107, doi. 10.1007/s10557-023-07507-3
- By:
- Publication type:
- Article
Does One Size Fits All?
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1099, doi. 10.1007/s10557-024-07625-6
- By:
- Publication type:
- Article
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Significant Mitral Stenosis—a Preliminary Meta-Analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 1059, doi. 10.1007/s10557-023-07451-2
- By:
- Publication type:
- Article
Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 731, doi. 10.1007/s10557-023-07433-4
- By:
- Publication type:
- Article
Direct Oral Anticoagulants: Navigating Through Clinical Challenges.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 637, doi. 10.1007/s10557-023-07499-0
- By:
- Publication type:
- Article
Correction to: Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants In Patients With Atrial Fibrillation: The ANATOLIA-AF Study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 581, doi. 10.1007/s10557-022-07409-w
- By:
- Publication type:
- Article
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 425, doi. 10.1007/s10557-022-07406-z
- By:
- Publication type:
- Article
Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 1, p. 109, doi. 10.1007/s10557-022-07381-5
- By:
- Publication type:
- Article
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 1031, doi. 10.1007/s10557-021-07302-y
- By:
- Publication type:
- Article
Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 6, p. 1077, doi. 10.1007/s10557-022-07357-5
- By:
- Publication type:
- Article
Efficacy and Safety of Direct Oral Anticoagulants (DOACs) Versus Warfarin in Atrial Fibrillation Patients with Prior Stroke: a Systematic Review and Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 6, p. 1225, doi. 10.1007/s10557-022-07336-w
- By:
- Publication type:
- Article
Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 4, p. 715, doi. 10.1007/s10557-022-07332-0
- By:
- Publication type:
- Article
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 4, p. 781, doi. 10.1007/s10557-021-07279-8
- By:
- Publication type:
- Article
A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 3, p. 519, doi. 10.1007/s10557-021-07298-5
- By:
- Publication type:
- Article
Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 2, p. 363, doi. 10.1007/s10557-021-07232-9
- By:
- Publication type:
- Article
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 973, doi. 10.1007/s10557-021-07211-0
- By:
- Publication type:
- Article
Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 891, doi. 10.1007/s10557-021-07200-3
- By:
- Publication type:
- Article
Association of Low Body Weight with Clinical Outcomes in Elderly Atrial Fibrillation Patients Receiving Apixaban—J-ELD AF Registry Subanalysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 4, p. 691, doi. 10.1007/s10557-021-07180-4
- By:
- Publication type:
- Article
Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 4, p. 679, doi. 10.1007/s10557-021-07170-6
- By:
- Publication type:
- Article
Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 4, p. 705, doi. 10.1007/s10557-021-07194-y
- By:
- Publication type:
- Article
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 4, p. 749, doi. 10.1007/s10557-020-07122-6
- By:
- Publication type:
- Article
Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 2, p. 333, doi. 10.1007/s10557-021-07171-5
- By:
- Publication type:
- Article
A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 2, p. 309, doi. 10.1007/s10557-021-07157-3
- By:
- Publication type:
- Article
Effects of sodium‐glucose co‐transporter 2 inhibitors on liver parameters and steatosis: A meta‐analysis of randomized clinical trials.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 6, p. 1, doi. 10.1002/dmrr.3413
- By:
- Publication type:
- Article
To stop or not to stop novel oral anticoagulants prior to performing joint interventional maneuvers? Evidence from a prospective study that the therapy can be maintained.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 9, p. 2983, doi. 10.1007/s10067-024-07048-6
- By:
- Publication type:
- Article
Is the use of direct oral anticoagulants after non-cardiac thoracic surgery safe for patients?
- Published in:
- Surgery Today, 2025, v. 55, n. 1, p. 116, doi. 10.1007/s00595-024-02942-7
- By:
- Publication type:
- Article